Follow
Annick TIBI
Annick TIBI
AP-HP et Université Paris Cité
Verified email at aphp.fr
Title
Cited by
Cited by
Year
Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial
O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ...
JAMA internal medicine 181 (1), 32-40, 2021
6102021
Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis
P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ...
Jama 326 (6), 499-518, 2021
2482021
Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma
A Carpentier, F Laigle-Donadey, S Zohar, L Capelle, A Behin, A Tibi, ...
Neuro-oncology 8 (1), 60-66, 2006
2302006
Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study
A Carpentier, P Metellus, R Ursu, S Zohar, F Lafitte, M Barrie, Y Meng, ...
Neuro-oncology 12 (4), 401-408, 2010
1882010
Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia
E Raffoux, P Rousselot, J Poupon, MT Daniel, B Cassinat, R Delarue, ...
Journal of clinical oncology 21 (12), 2326-2334, 2003
1872003
Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial
X Duval, S Van Der Werf, T Blanchon, A Mosnier, ...
PLoS medicine 7 (11), e1000362, 2010
1482010
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
PL Tharaux, G Pialoux, A Pavot, X Mariette, O Hermine, M Resche-Rigon, ...
The Lancet Respiratory Medicine 9 (3), 295-304, 2021
1192021
Intracerebral injection of CpG oligonucleotide for patients with de novo glioblastoma—a phase II multicentric, randomised study
R Ursu, A Carpentier, P Metellus, V Lubrano, F Laigle-Donadey, ...
European Journal of Cancer 73, 30-37, 2017
702017
Phase II study of pembrolizumab as first-line, single-drug therapy for patients with unresectable cutaneous squamous cell carcinomas
E Maubec, M Boubaya, P Petrow, M Beylot-Barry, N Basset-Seguin, ...
Journal of Clinical Oncology 38 (26), 3051-3061, 2020
592020
A bacterial biofilm in a hemodialysis system. Assessment of disinfection and crossing of endotoxin.
FC Vincent, AR Tibi, JC Darbord
ASAIO transactions 35 (3), 310-313, 1989
421989
Very low oral doses of vitamin B-12 increase serum concentrations in elderly subjects with food-bound vitamin B-12 malabsorption
J Blacher, S Czernichow, M Raphaöl, C Roussel, ...
The Journal of nutrition 137 (2), 373-378, 2007
372007
Effect of oseltamivir, zanamivir or oseltamivir–zanamivir combination treatments on transmission of influenza in households
F Carrat, X Duval, F Tubach, A Mosnier, S Van der Werf, A Tibi, ...
Antiviral therapy 17 (6), 1085-1090, 2012
312012
Pembrolizumab as first line therapy in patients with unresectable squamous cell carcinoma of the skin: Interim results of the phase 2 CARSKIN trial.
E Maubec, M Boubaya, P Petrow, N Basset-Seguin, JJ Grob, B Dreno, ...
Journal of Clinical Oncology 36 (15_suppl), 9534-9534, 2018
292018
Immunotherapy with CpG‐ODN in neoplastic meningitis: A phase I trial
R Ursu, S Taillibert, C Banissi, E Vicaut, O Bailon, E Le Rhun, JS Guillamo, ...
Cancer Science 106 (9), 1212-1218, 2015
282015
Prevalence of BSE in western France by screening cattle at risk: preliminary results of a pilot study
D Calavas, C Ducrot, T Baron, E Morignat, JL Vinard, AG Biacabe, ...
Veterinary Record 149 (2), 55-55, 2001
262001
A study of the relative bioavailability of cysteamine hydrochloride, cysteamine bitartrate and phosphocysteamine in healthy adult male volunteers
L Tennezé, V Daurat, A Tibi, P Chaumet‐Riffaud, C Funck‐Brentano
British journal of clinical pharmacology 47 (1), 49-52, 1999
231999
Pembrolizumab as first-line therapy in patients with unresectable cutaneous squamous cell carcinoma (cSCC): Phase 2 results from CARSKIN.
E Maubec, M Boubaya, P Petrow, N Basset-Seguin, JJ Grob, B Dréno, ...
Journal of Clinical Oncology 37 (15_suppl), 9547-9547, 2019
212019
Rationale and design of the multicenter randomized trial investigating the effects of levosimendan pretreatment in patients with low ejection fraction (≤ 40%) undergoing CABG …
T Caruba, D Hourton, B Sabatier, D Rousseau, A Tibi, C Hoffart-Jourdain, ...
Journal of Cardiothoracic Surgery 11 (1), 1-7, 2016
192016
de Thé H, Degos L, Hermine O, Dombret H.. Combined treatment with arsenic trioxide and all trans-retinoic acid in patients with relapsed acute promyelocytic leukemia
E Raffoux, P Rousselot, J Poupon, MT Daniel, B Cassinat, R Delarue, ...
J Clin Oncol 21 (12), 2326-2334, 2003
142003
Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial
X Mariette, O Hermine, PL Tharaux, M Resche-Rigon, R Porcher, ...
The Lancet Rheumatology 4 (1), e24-e32, 2022
122022
The system can't perform the operation now. Try again later.
Articles 1–20